Insider Trading activities of Beigene, Ltd. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Beigene, Ltd. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Beigene, Ltd. since year 2005. Table 2 shows the detailed insider transactions of Beigene, Ltd. since 2005. The reporting company's ticker symbol is BGNE. The reporting company's CIK number is 1651308.
The total value of stock buying since 2005 is $270,156,564.
The total value of stock sales since 2005 is $105,170,713.
The total value of stock option exercises since 2005 is $567,775.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Beigene, Ltd. (BGNE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-07 0 $0 2,550 $418,498 0 $0
2018-03 0 $0 104,662 $15,706,901 35,000 $227,500
2018-02 0 $0 44,338 $6,543,876 10,000 $266,500
2018-01 1,980,198 $199,999,998 0 $0 0 $0
2017-12 0 $0 167,737 $15,920,903 2,500 $73,775
2017-11 0 $0 242,064 $19,894,655 0 $0
2017-08 176,056 $12,499,976 0 $0 0 $0
2017-07 0 $0 250,210 $16,369,238 0 $0
2017-06 0 $0 139,039 $6,190,546 0 $0
2017-05 0 $0 16,561 $678,283 0 $0
2017-04 0 $0 45,699 $1,803,324 0 $0
2017-03 0 $0 215,987 $8,617,448 0 $0
2017-02 0 $0 103,314 $4,098,093 0 $0
2016-11 1,790,495 $57,295,840 93,750 $3,000,000 0 $0
2016-09 0 $0 192,307 $5,928,948 0 $0
2016-02 9,295,000 $360,750 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Beigene, Ltd. insiders (BGNE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-07-16 Oyler John (Chief Executive Officer) Sale 2,550 164.12 418,498
2018-03-19 Liang Howard (CFO & Chief Strategy Officer) Sale 29,128 161.56 4,705,919
2018-03-19 Liang Howard (CFO & Chief Strategy Officer) Option Ex 24,128 6.50 156,832
2018-03-16 Liang Howard (CFO & Chief Strategy Officer) Sale 10,872 156.77 1,704,414
2018-03-16 Liang Howard (CFO & Chief Strategy Officer) Option Ex 10,872 6.50 70,668
2018-03-02 Oyler John (Chief Executive Officer) Sale 25,362 146.20 3,707,873
2018-03-01 Oyler John (Chief Executive Officer) Sale 39,300 142.21 5,588,695
2018-02-28 Li Ji (EVP and Gl. Head of Bus. Dev.) Sale 10,000 146.59 1,465,870
2018-02-28 Li Ji (EVP and Gl. Head of Bus. Dev.) Option Ex 10,000 26.65 266,500
2018-02-28 Oyler John (Chief Executive Officer) Sale 34,338 147.88 5,078,006
2018-01-18 Baker Julian (Director) Buy 1,980,198 101.00 199,999,998
2017-12-26 Oyler John (Chief Executive Officer) Sale 20,137 97.84 1,970,163
2017-12-21 Huang Jane (CMO, Hematology) Sale 1,000 98.00 98,000
2017-12-21 Huang Jane (CMO, Hematology) Option Ex 1,000 29.51 29,510
2017-12-13 Huang Jane (CMO, Hematology) Sale 1,500 94.37 141,556
2017-12-13 Huang Jane (CMO, Hematology) Option Ex 1,500 29.51 44,265
2017-12-08 Oyler John (Chief Executive Officer) Sale 52,817 95.73 5,056,329
2017-12-07 Oyler John (Chief Executive Officer) Sale 59,737 94.50 5,645,086
2017-12-06 Oyler John (Chief Executive Officer) Sale 31,446 92.70 2,915,169
2017-12-04 Huang Jane (CMO, Hematology) Sale 1,100 86.00 94,600
2017-11-29 Oyler John (Chief Executive Officer) Sale 36,340 82.92 3,013,458
2017-11-28 Oyler John (Chief Executive Officer) Sale 32,985 85.52 2,820,877
2017-11-27 Oyler John (Chief Executive Officer) Sale 16,581 87.12 1,444,536
2017-11-20 Huang Jane (CMO, Hematology) Sale 1,000 87.00 87,000
2017-11-16 Huang Jane (CMO, Hematology) Sale 600 85.00 51,000
2017-11-15 Oyler John (Chief Executive Officer) Sale 66,068 80.10 5,291,782
2017-11-14 Oyler John (Chief Executive Officer) Sale 59,835 80.21 4,799,544
2017-11-13 Peterson Amy C. (CMO, Immuno-oncology) Sale 3,601 83.05 299,059
2017-11-13 Oyler John (Chief Executive Officer) Sale 25,054 83.32 2,087,399
2017-08-11 Baker Brothers Life Sciences Lp (Director) Buy 176,056 71.00 12,499,976
2017-07-12 Wang Xiaodong Sale 20,000 72.49 1,449,740
2017-07-10 Glazer Donald W. (Director) Sale 10,810 72.04 778,730
2017-07-06 Oyler John (Chief Executive Officer) Sale 219,400 64.45 14,140,768
2017-06-28 Wang Xiaodong Sale 35,000 45.17 1,581,090
2017-06-23 Oyler John (Chief Executive Officer) Sale 39,895 44.73 1,784,662
2017-06-22 Oyler John (Chief Executive Officer) Sale 58,605 44.42 2,603,234
2017-06-02 Wang Xiaodong Sale 5,539 40.00 221,560
2017-05-04 Wang Xiaodong Sale 4,491 41.01 184,171
2017-05-03 Wang Xiaodong Sale 9,970 40.71 405,868
2017-05-01 Oyler John (Chief Executive Officer) Sale 2,100 42.02 88,244
2017-04-27 Oyler John (Chief Executive Officer) Sale 34,049 40.37 1,374,558
2017-04-05 Wang Xiaodong Sale 11,650 36.80 428,766
2017-03-24 Wang Xiaodong Sale 18,787 36.93 693,841
2017-03-23 Wang Xiaodong Sale 11,041 36.99 408,461
2017-03-22 Wang Xiaodong Sale 8,279 37.75 312,515
2017-03-20 Oyler John (Chief Executive Officer) Sale 13,234 40.02 529,611
2017-03-17 Oyler John (Chief Executive Officer) Sale 2,717 40.02 108,737
2017-03-16 Oyler John (Chief Executive Officer) Sale 16,038 39.06 626,508
2017-03-10 Wang Xiaodong (Director) Sale 7,304 39.94 291,699
2017-03-09 Wang Xiaodong (Director) Sale 18,596 39.95 742,835
2017-03-08 Wang Xiaodong (Director) Sale 10,992 39.77 437,206
2017-03-06 Oyler John (Chief Executive Officer) Sale 19,816 40.43 801,220
2017-03-03 Oyler John (Chief Executive Officer) Sale 40,091 40.90 1,639,721
2017-03-02 Oyler John (Chief Executive Officer) Sale 49,092 41.25 2,025,094
2017-02-27 Wang Xiaodong (Director) Sale 4,444 38.10 169,329
2017-02-24 Wang Xiaodong (Director) Sale 28,402 38.34 1,088,819
2017-02-23 Wang Xiaodong (Director) Sale 5,505 38.57 212,349
2017-02-21 Oyler John (Chief Executive Officer) Sale 10,359 40.09 415,344
2017-02-17 Oyler John (Chief Executive Officer) Sale 7,204 40.67 292,979
2017-02-16 Oyler John (Chief Executive Officer) Sale 47,400 40.49 1,919,273
2016-11-23 Wang Xiaodong (Director) Sale 93,750 32.00 3,000,000
2016-11-23 Malley Thomas Buy 30,000 32.00 960,000
2016-11-18 14159, L.p. (Director) Buy 1,760,495 32.00 56,335,840
2016-09-28 Glazer Donald W. Sale 41,463 30.82 1,277,682
2016-09-27 Glazer Donald W. Sale 26,483 29.63 784,691
2016-09-26 Glazer Donald W. Sale 20,666 29.58 611,300
2016-09-23 Glazer Donald W. Sale 11,433 30.77 351,793
2016-09-22 Glazer Donald W. Sale 25,010 31.13 778,561
2016-09-21 Glazer Donald W. Sale 16,318 31.19 508,958
2016-09-20 Glazer Donald W. Sale 8,243 31.01 255,615
2016-09-19 Glazer Donald W. Sale 42,691 31.86 1,360,348
2016-02-08 Yuan Ruirong (Chief Medical Officer) Buy 130,000 1.85 240,500
2016-02-08 Liang Howard (CFO & Chief Strategy Officer) Buy 65,000 1.85 120,250
2016-02-08 Hillhouse Capital Management, Ltd. Buy 9,100,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of BGNE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Beigene, Ltd. (symbol BGNE, CIK number 1651308) see the Securities and Exchange Commission (SEC) website.